Medical Design & Outsourcing11d
As Abbott studies DBS for depression, what might be next?
Abbott Neuromodulation's Jenn Wong discusses the TRANSCEND trial for depression, imaging tech advancing DBS and other ...
pharmaphorum6y
Abbott upgrades brain implant software
The US Food and Drug Administration has approved an over-the-air software upgrade for Infinity implants manufactured by Abbott, giving devices ... DBS systems, adding full-body MRI conditional ...
GlobalData on MSN26d
Abbott’s brain stimulation trial for depression kicks off at Mount Sinai
Abbott received a breakthrough device designation from the US Food and Drug Administration (FDA) to investigate the use of ...
EurekAlert!27d
Mount Sinai is first in the nation to perform deep brain stimulation implant as part of clinical trial for depression
DBS for treatment-resistant depression has not been approved by the U.S Food and Drug Administration (FDA) and the safety and ... September 2022, Abbott received Breakthrough Device designation ...